Rate My Professor Patricia Price

Dr. Patricia Price serves as Adjunct Associate Professor in the Faculty of Health Sciences at Curtin University, where her research centers on viral immunology. She investigates the pathological effects of cytomegalovirus (CMV), a common virus benign in healthy individuals but significant in those with compromised immunity, particularly in HIV patients and age-related diseases. Her work explores CMV's contributions to cardiovascular changes, sensory neuropathy, and immune recovery during antiretroviral therapy. Associate Professor Price leads the JakCCANDO project (Jakarta CMV, Cardiovascular, Antiretroviral, Neuropathy, Dental, Ophthalmology) in collaboration with the University of Indonesia, assessing 82 HIV patients' oral health, neurocognitive status, cardiovascular system, and retinal health upon commencing therapy to detect CMV reactivation and compare immune profiles to healthy controls. This initiative, started in 2008, extends to similar studies with the University of the Witwatersrand in Johannesburg on neuropathy pathogenesis in HIV contexts. She mentors Indonesian and South African research students, providing hands-on laboratory training at Curtin University.

Price earned her PhD in 1985 and has held a professorship in the School of Pathology and Laboratory Medicine at the University of Western Australia since 1996. At Curtin, she was Principal Research Fellow from 2015 to 2020, contributing to the Curtin Medical Research Institute, and remains active as adjunct staff. She serves as Editor in Chief of AIDS Research and Therapy. Her scholarly impact is substantial, with 10,582 citations and an h-index of 47 on Google Scholar. Notable publications include 'Human Cytomegalovirus Infection and Cardiovascular Disease: Current Perspectives' (2023), 'Expression in skin biopsies supports genetic evidence linking CAMKK2, P2X7R and P2X4R with HIV-associated sensory neuropathy' (2023), 'Long-Term Associations between Human Cytomegalovirus Antibody Levels with All-Cause Mortality and Cardiovascular Outcomes in an Australian Community-Based Cohort' (2022), 'The Detection of CMV in Saliva Can Mark a Systemic Inflammation Signature in HIV Patients Stable on ART' (2019), and 'Active and Persistent Cytomegalovirus Infections Affect T-cells in Young Adult HIV Patients Commencing Antiretroviral Therapy' (2018).